Which medications in the drug class Sphingosine 1-Phosphate Receptor Modulators are used in the treatment of Pediatric Multiple Sclerosis?

Updated: Jan 30, 2019
  • Author: Alice K Rutatangwa, DO, MSc; Chief Editor: Amy Kao, MD  more...
  • Print

Sphingosine 1-Phosphate Receptor Modulators

These agents may block lymphocyte capacity to egress from lymph nodes, and thereby reduce lymphocyte migration into the CNS.

Fingolimod (Gilenya)

Sphingosine 1-phosphate receptor modulator. Fingolimod is the first drug approved for children aged >10 years with relapsing forms of MS.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!